A Vachálková

931 total citations
52 papers, 807 citations indexed

About

A Vachálková is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, A Vachálková has authored 52 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 27 papers in Molecular Biology and 8 papers in Biochemistry. Recurrent topics in A Vachálková's work include Free Radicals and Antioxidants (10 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Phytochemicals and Antioxidant Activities (8 papers). A Vachálková is often cited by papers focused on Free Radicals and Antioxidants (10 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Phytochemicals and Antioxidant Activities (8 papers). A Vachálková collaborates with scholars based in Slovakia, Kuwait and Austria. A Vachálková's co-authors include Ladislav Novotný, K Horváthová, Z Ovesná, P Rauko, David Biggs, Darina Tóthová, Luboš Čipák, Lawrence Novotny, Ivan Chalupa and Mohammed E. Abdel‐Hamid and has published in prestigious journals such as Journal of Chromatography A, Life Sciences and Advances in experimental medicine and biology.

In The Last Decade

A Vachálková

50 papers receiving 774 citations

Peers

A Vachálková

BIOCH

PHARM

Miyako Haneda Japan

Koji Furuno Japan

Ryoko Tsubouchi Japan

Louis Jung France

Sumati V. Bhide India

Matthew S. Brignall United States

Sheikh M. Hadi India

Vernon E. Steele United States

Ching-Quo Wong United States

Ae Ra Kim South Korea

Miyako Haneda Japan

A Vachálková

288 ×0.8

132 ×0.7

BIOCH

165 ×1.0

123 ×1.0

89 ×0.9

PHARM

Citations per year, relative to A Vachálková A Vachálková (= 1×) peers Miyako Haneda

Countries citing papers authored by A Vachálková

Since Specialization

Citations

This map shows the geographic impact of A Vachálková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Vachálková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Vachálková more than expected).

Fields of papers citing papers by A Vachálková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Vachálková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Vachálková. The network helps show where A Vachálková may publish in the future.

Co-authorship network of co-authors of A Vachálková

This figure shows the co-authorship network connecting the top 25 collaborators of A Vachálková. A scholar is included among the top collaborators of A Vachálková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Vachálková. A Vachálková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horváthová, K, et al.. (2004). Protective effect of quercetin and luteolin in human melanoma HMB-2 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 565(2). 105–112. 60 indexed citations

Cojocel, C., et al.. (2003). Comparison of the carcinogenic potential of streptozotocin by polarography and alkaline elution.. PubMed. 50(2). 110–6. 7 indexed citations

Horváthová, K, et al.. (2001). Flavonoids as chemoprotective agents in civilization diseases.. PubMed. 48(6). 435–41. 27 indexed citations

Grančai, D, et al.. (2000). Determination of apigenin in rat plasma by high-performance liquid chromatography. Journal of Chromatography A. 870(1-2). 463–467. 38 indexed citations

Vachálková, A, et al.. (2000). Potential carcinogenic and inhibitory activity of compounds isolated from Lilium candidum L.. PubMed. 47(5). 313–8. 16 indexed citations

Vachálková, A, et al.. (1999). UV spectrometric and DC polarographic studies on apigenin and luteolin. Archives of Pharmacal Research. 22(2). 173–178. 9 indexed citations

Dovinová, Ima, A Vachálková, & Ladislav Novotný. (1999). Potential carcinogenicity of some transition metal ions. Biological Trace Element Research. 67(1). 63–73. 2 indexed citations

Novotný, Ladislav, A Vachálková, & A. Pískala. (1999). Polarographic properties and potential carcinogenicity of some natural nucleosides and their synthetic analogues. Bioelectrochemistry and Bioenergetics. 48(1). 129–134. 4 indexed citations

Fritzer‐Szekeres, Monika, et al.. (1998). Iron Binding Capacity of Didox (3,4 Dihydroxybenzohydroxamic Acid) and Amidox (3,4 Dihydroxybenzamidoxime) two Inhibitors of the Enzyme Ribonucleotide Reductase. Advances in experimental medicine and biology. 431. 599–604. 3 indexed citations

10.

Fritzer‐Szekeres, Monika, Ladislav Novotný, Ján Sedlák, et al.. (1998). Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia. Life Sciences. 63(7). 545–552. 17 indexed citations

11.

Vachálková, A, et al.. (1997). The new inhibitors of ribonucleotide reductase—comparison of some physico-chemical properties. Journal of Pharmaceutical and Biomedical Analysis. 15(7). 951–956. 1 indexed citations

12.

Fritzer‐Szekeres, Monika, et al.. (1997). Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase. Life Sciences. 61(22). 2231–2237. 7 indexed citations

13.

Vachálková, A, et al.. (1996). Polarographic reduction of some triphenylmethane dyes and their potential carcinogenic activity.. PubMed. 43(2). 113–7. 26 indexed citations

14.

Novotný, Ladislav, et al.. (1996). Potential carcinogenicity of the synthetic 1,3,6-triazine (6-aza) nucleic acid analogues determined by DC polarography. I. Nucleobases.. PubMed. 43(6). 403–6. 3 indexed citations

15.

Szekeres, Thomas, et al.. (1995). Iron Binding Capacity of Trimidox (3,4,5-Trihydroxybenzamidoxime), a New Inhibitor of the Enzyme Ribonucleotide Reductase. Clinical Chemistry and Laboratory Medicine (CCLM). 33(11). 785–790. 19 indexed citations

16.

Novotný, Ladislav, A Vachálková, & A. Pískala. (1995). Polarographic Reduction and Potential Carcinogenity of Substituted 1,3,5-Triazine Nucleosides. Collection of Czechoslovak Chemical Communications. 60(9). 1469–1475. 4 indexed citations

17.

Vachálková, A, Ladislav Novotný, & A. Pískala. (1993). Polarographic reduction and carcinogenic index tg alpha of 5-aza nucleosides possessing antileukemic activity.. PubMed. 40(5). 289–92. 7 indexed citations

18.

Vachálková, A, et al.. (1982). Electrochemical properties of polycyclic compounds studied by the polarographic method in anhydrous systems. VIII. The influence of proton-donor on reduction of carcinogenic nitrogen compounds in dimethylformamide.. PubMed. 29(2). 161–7. 1 indexed citations

19.

Benešová, Monika, et al.. (1978). Carcinogenicity and polarographic behavior of dibenz[a,h]anthracene, dibenz[a,h]acridine and dibenz[a,h]phenazine.. PubMed. 25(6). 641–5. 3 indexed citations

20.

Vachálková, A, et al.. (1975). Electrochemical properties of polycyclic compounds studied by the polarographic method in anhydrous systems. II. Polarographic study of carcinogenic nitrogen compounds in dimethylformamide and comparison of half-wave potentials with quantum-chemical calculations of molecular orbitals.. PubMed. 22(5). 469–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact